Stay updated with breaking news from Thomas lodise. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Infection Intel: Updates From Crothall Healthcare and Ascendco Health, Freestyle Partners, and Shionogi & Co infectioncontroltoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infectioncontroltoday.com Daily Mail and Mail on Sunday newspapers.
Third-Generation Quinolones May Be Safer for Tendons medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Utility Therapeutics Ltd.: UTILITY Therapeutics Announces Scientific Advisory Board SAB includes key opinion leaders for infectious diseases and urinary tract infections LONDON, UK / ACCESSWIRE / May 11, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI), announced today that it has established a Scientific Advisory Board (SAB) that will be chaired by Keith A. Rodvold, PharmD and Distinguished Professor of Pharmacy at the College of Medicine at the University of Illinois in Chicago. We are honored to have such a prestigious and experienced group of medical and industry experts join our Scientific Advisory Board, stated Tom Hadley, President and Chief Commercial Officer of UTILITY therapeutics. Their guidance will be extremely valuable as we advance our two product candidates for the treatment of UTIs. We look forw ....
UTILITY Therapeutics Announces Scientific Advisory Board ACCESSWIRE SAB includes key opinion leaders for infectious diseases and urinary tract infections LONDON, UK / ACCESSWIRE / May 11, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI), announced today that it has established a Scientific Advisory Board (SAB) that will be chaired by Keith A. Rodvold, PharmD and Distinguished Professor of Pharmacy at the College of Medicine at the University of Illinois in Chicago. We are honored to have such a prestigious and experienced group of medical and industry experts join our Scientific Advisory Board, stated Tom Hadley, President and Chief Commercial Officer of UTILITY therapeutics. Their guidance will be extremely valuable as we advance our two product candidates for the treatment of UTIs. We look forward to worki ....